Capesaris

On the Horizon- A Better ADT Treatment with Less Side Effects

GTx Inc. had a poster honored as one of the best posters at the 28th Annual European Association of Urology Congress held in Milan Italy March 15 2013. The poster presentation which had the very long title of “GTx-758 an ERa Agonist Reduces Serum Free Testosterone Lower than can be Achieved by Leuprolide with a [...]

By Malecare|2017-10-19T10:50:02-04:00April 7th, 2013|Advanced Prostate Cancer, Capesaris, Clinical Trials, Clinical Trials, Drugs & Treatments, Hormone Therapy, On The Horizon, Uncategorized|0 Comments

GTx Receives clearance for New Capesaris Trials

GTx Inc. announced that FDA regulators will allow it to restart the clinical trials of its investigational prostate cancer drug Capesaris for men with castrate resistant advanced prostate cancer. They anticipate that the trials of Capesaris will begin during the third quarter of 2012. The trial is designed to evaluate Capesaris as a secondary treatment [...]

By Malecare|2012-05-08T20:17:57-04:00May 8th, 2012|2nd line hormone therapy, Advanced Prostate Cancer, Capesaris, C